Volume 26, Issue 1 (4-2024)
yafte 2024, 26(1): 73-84 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Adel A, Abdi M, Shahsavari A, Sepahvand M, Khanahmadi S. Frequency of Menstrual Disturbances and Related Factors in Women with COVID-19. yafte 2024; 26 (1) :73-84
URL: http://yafte.lums.ac.ir/article-1-3700-en.html
URL: http://yafte.lums.ac.ir/article-1-3700-en.html
Aligudarz School of Nursing, Lorestam University of Medical Sciences, Khorram Abad, Iran & Aligudarz School of Nursing, Lorestam University of Medical Sciences, Khorram Abad, Iran
Abstract: (410 Views)
Background: COVID-19 was a global epidemic that led to numerous problems, including menstrual disorders in women. The present study aimed to assess the frequency of menstrual disorders and related factors in women with COVID-19.
Materials and Methods: The descriptive study was conducted on 80 women with COVID-19 in the first six months of 2022. Information was collected using a telephone questionnaire and data analysis was performed in SPSS software (version 16) using descriptive statistics (frequency and percentage) and analysis (chi-square and independent t-test).
Results: Based on the results, 43.7% of women had menstrual disorders during the COVID-19 pandemic. Among these women, 26.3% and 17.5% of cases considered the disorder to be related to receiving the COVID-19 vaccine and COVID-19 infection, respectively. Massive bleeding (17.5%) and low-volume bleeding (7.5%) were the most reported disorders, and Sinopharm (76.3%) and AstraZeneca (15.0%) vaccines were the most used vaccines. The results of statistical tests did not demonstrate a significant relationship between the presence of disorder and other variables (P>0.05).
Conclusion: Menstrual disorders increased during COVID-19 compared to before. Considering the resolution of this disorder after several months, it is recommended that if the disorder is not resolved, it should be referred for identification and follow-up in time to reduce the dangerous consequences of women's diseases.
Materials and Methods: The descriptive study was conducted on 80 women with COVID-19 in the first six months of 2022. Information was collected using a telephone questionnaire and data analysis was performed in SPSS software (version 16) using descriptive statistics (frequency and percentage) and analysis (chi-square and independent t-test).
Results: Based on the results, 43.7% of women had menstrual disorders during the COVID-19 pandemic. Among these women, 26.3% and 17.5% of cases considered the disorder to be related to receiving the COVID-19 vaccine and COVID-19 infection, respectively. Massive bleeding (17.5%) and low-volume bleeding (7.5%) were the most reported disorders, and Sinopharm (76.3%) and AstraZeneca (15.0%) vaccines were the most used vaccines. The results of statistical tests did not demonstrate a significant relationship between the presence of disorder and other variables (P>0.05).
Conclusion: Menstrual disorders increased during COVID-19 compared to before. Considering the resolution of this disorder after several months, it is recommended that if the disorder is not resolved, it should be referred for identification and follow-up in time to reduce the dangerous consequences of women's diseases.
Type of Study: Research |
Subject:
زنان
Received: 2024/01/4 | Accepted: 2024/05/14 | Published: 2024/04/29
Received: 2024/01/4 | Accepted: 2024/05/14 | Published: 2024/04/29
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
